The pyrazolo[3,4-d]pyrimidine derivative CLM24 has an antineoplastic effect in aggressive dedifferentiated thyroid cancer in vitro.

Saved in:
Bibliographic Details
Title: The pyrazolo[3,4-d]pyrimidine derivative CLM24 has an antineoplastic effect in aggressive dedifferentiated thyroid cancer in vitro.
Authors: Ferrari SM; Department of Surgery, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, 56126, Italy., Ragusa F; Department of Surgery, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, 56126, Italy., Elia G; Department of Surgery, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, 56126, Italy., Mazzi V; Department of Surgery, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, 56126, Italy., Balestri E; Department of Surgery, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, 56126, Italy., Botrini C; Department of Surgery, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, 56126, Italy., Rugani L; Department of Surgery, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, 56126, Italy., Piaggi S; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, 56126, Italy., La Motta C; Department of Pharmacy, University of Pisa, Pisa, 56126, Italy., Antonelli G; Department of Surgery, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, 56126, Italy., Ulisse S; Department of Surgery, 'Sapienza' University of Rome, Rome, 00161, Italy., Virili C; Department of Medico-Surgical Sciences and Biotechnologies, Endocrinology Section, 'Sapienza' University of Rome, Latina, 04100, Italy., Varricchi G; Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.; World Allergy Organization (WAO), Center of Excellence, Naples, Italy.; Institute of Experimental Endocrinology and Oncology (IEOS), National Research Council, Naples, Italy., Cantini G; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, 50139, Italy., Fabrazzo O; Department of Surgery, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, 56126, Italy., Romizi EC; Department of Surgery, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, 56126, Italy., Martino MG; Department of Surgery, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, 56126, Italy., Luconi M; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, 50139, Italy., Materazzi G; Department of Surgery, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, 56126, Italy., Antonelli A; Department of Surgery, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, 56126, Italy. alessandro.antonelli@unipi.it., Fallahi P; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, 56126, Italy.
Source: Endocrine [Endocrine] 2026 Apr 02; Vol. 91 (1). Date of Electronic Publication: 2026 Apr 02.
Publication Type: Journal Article
Journal Info: Publisher: Humana Press Country of Publication: United States NLM ID: 9434444 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-0100 (Electronic) Linking ISSN: 1355008X NLM ISO Abbreviation: Endocrine Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first